Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBy day 3 of Wegovy, many people notice that nausea, fatigue or digestive discomfort peaks rather than fades. This is normal and well-documented in clinical experience: semaglutide slows gastric emptying, and the first 72 hours are often the most unsettled. Wegovy is a prescription-only medicine; a registered prescriber assesses suitability before it is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people worry about on day 3 is that feeling rough means something has gone wrong. It hasn't. Semaglutide, the active medicine in Wegovy, works partly by slowing the rate at which food leaves your stomach. That mechanism is the reason it reduces appetite so effectively, and it is also the reason your digestive system needs a little time to adjust. The full picture of how Wegovy works is worth reading before you start, because understanding the mechanism makes day 3 feel less alarming and more predictable.
Day 3 is the tail-end of the window when semaglutide levels are still climbing after your first injection. Levels typically peak around 24–48 hours post-injection, but the GI effects can lag slightly behind, landing hardest on days 2–4. By the end of the first week, most people report a noticeable improvement. That pattern is consistent with what was observed across the STEP programme, the large clinical trial series that led to Wegovy's UK licence, published in the New England Journal of Medicine.
The misconception worth correcting plainly: feeling unwell on day 3 is not evidence of intolerance, allergy, or treatment failure. It is, for many people, the predictable result of a medicine doing exactly what it was designed to do.
The most frequently reported experiences around day 3 include nausea (sometimes with vomiting), loose stools or constipation, belching, tiredness and a low-grade headache. Injection-site redness or mild soreness from the first pen is also common at this stage. None of these are unusual, and the NHS semaglutide patient information lists them as known and expected effects of the medicine.
There is one symptom pattern that does warrant same-day contact with a doctor: severe, persistent abdominal pain that radiates to the back, with or without vomiting. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as an infrequent but serious known side effect. It is rare. Most stomach discomfort on day 3 is ordinary GI adjustment. But that specific combination of severe back-reaching pain is the signal to act quickly rather than rest and wait.
Dizziness on day 3 sometimes catches people off guard. It is usually linked to eating less without drinking enough fluid; semaglutide's appetite-suppressing effect can mean you forget to drink as well as eat. A glass of water before you do anything else in the morning is a practical habit worth starting on day 1. If you are curious how day 3 compares with what came before it, the day 2 Wegovy page runs through the earlier phase in detail.
Small portions, eaten slowly, are genuinely easier on the stomach than trying to eat a normal-sized meal. Bland foods (plain rice, toast, boiled potatoes) ask less of a stomach that is already working more slowly than usual. Fatty, very spicy or heavily processed food tends to make nausea worse on day 3, not because Wegovy is reacting to those foods specifically, but because slower digestion means they sit longer. Most people find it useful to eat sitting upright and to avoid lying down for at least an hour after food.
Sleep and rest are underrated. Fatigue on day 3 is partly the medicine, partly the disrupted eating, and partly the simple fact that your body is adapting. Trying to push through exhaustion with caffeine on an already unsettled stomach usually makes things worse. If you have the flexibility, keeping the afternoon of injection day (and the two days following) lighter in commitments takes the pressure off. Some people time their weekly injection for a Thursday evening so that the peak discomfort lands over the weekend rather than a busy Monday morning before the school run.
For a broader view of how the first week unfolds day by day, the Wegovy day-by-day guide covers what to expect from injection day through to day 7 and beyond. And if you want to understand where day 3 sits within the overall semaglutide experience, semaglutide day 3 approaches the same window from a slightly different angle.
Most people feel meaningfully better by days 5–7 of their first injection. The starter dose of Wegovy (0.25mg weekly) is intentionally low; its job is to let your system adjust before the prescriber titrates upward. If day 3 is genuinely difficult, that is not a reason to stop. It is worth noting in a diary or on your pharmacy's aftercare channel, because that pattern of early nausea often improves substantially with dose and lifestyle habits over the following injections.
There are occasional cases where side effects remain severe beyond the first week, or where a particular symptom raises a clinical question. In those cases, speaking to your prescriber is the right step, not stopping treatment unilaterally. Adjustments to the titration schedule, or practical guidance on food choices, can make a significant difference. You can find the broader context for starting Wegovy, including what to expect across the first few days, on the day 1 Wegovy page. Cost and ongoing access questions are covered separately on the Wegovy cost page.
If some of the GI effects that show up on day 3 persist (particularly increased wind) the guide to ongoing flatulence on Wegovy explains what drives it and what tends to help. Wegovy is a prescription-only medicine; any decision about continuing, pausing or adjusting treatment sits with your prescriber, not with a self-assessment alone.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.